CIK 0001761612 · Non-accelerated filer<br>Smaller reporting company
BICYCLE THERAPEUTICS PLC
Sign in to watch- Ticker
- BCYC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 011441223261503
- Business address
- BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
- Former names
- BICYCLE THERAPEUTICS Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $64,039
- in 7 filings, $7K under 10b5-1 plans
Net −$64,039. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Lee Kevin −$27K CHIEF EXECUTIVE OFFICER sold 1% of stake
- Swanton Robert Charles −$12K Director sold 18% of stake
- Skynner Michael −$9K CHIEF SCIENTIFIC OFFICER sold 2% of stake
- Perry Jennifer Scott −$7K Chief Operating Officer sold 2% of stake
- Hannay Michael Charles Ferguson −$6K CHIEF PROD & SUPPLY CHAIN OFF sold 2% of stake
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-02 | Hoppenot Herve Director | Grant or award | +3,032 | 15,532 | ||
| 2026-01-02 | Hoppenot Herve Director | Grant or award · Stock Option (right to buy) | +6,065 | 6,065 | ||
| 2026-01-02 | BAKER BROS. ADVISORS LP Director | Grant or award | +19,000 | 937,483 | ||
| 2026-01-02 | BAKER BROS. ADVISORS LP Director | Grant or award | +19,000 | 10,018,674 | ||
| 2026-01-02 | BAKER BROS. ADVISORS LP Director | Grant or award · Share Option (Right to Buy) | +38,000 | 38,000 | ||
| 2026-01-02 | BAKER BROS. ADVISORS LP Director | Grant or award · Share Option (Right to Buy) | +38,000 | 38,000 | ||
| 2025-10-03 | Hannay Michael Charles Ferguson CHIEF PROD & SUPPLY CHAIN OFF | Sale | −250 | $8.41 | $2K | 53,102 |
| 2025-10-03 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | Sale | −103 | $8.41 | $866 | 31,197 |
| 2025-10-03 | Milnes Alistair CHIEF OPERATING OFFICER | Sale | −978 | $8.41 | $8K | 93,377 |
| 2025-10-03 | Lee Kevin CHIEF EXECUTIVE OFFICER | Sale | −3,231 | $8.41 | $27K | 475,310 |
| 2025-10-03 | Skynner Michael CHIEF TECHNOLOGY OFFICER | Sale | −978 | $8.41 | $8K | 118,277 |
| 2025-10-02 | Swanton Robert Charles Director | Sale 10b5-1 | −102 | $8.55 | $872 | 15,487 |
| 2025-10-02 | Hannay Michael Charles Ferguson CHIEF PROD & SUPPLY CHAIN OFF | Sale | −473 | $8.40 | $4K | 53,352 |
| 2025-10-02 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | Sale | −221 | $8.40 | $2K | 31,300 |
| 2025-10-02 | Young Alethia Chief Financial Officer | Sale 10b5-1 | −217 | $8.40 | $2K | 44,969 |
| 2025-10-02 | Young Alethia Chief Financial Officer | Sale 10b5-1 | −265 | $8.61 | $2K | 44,704 |
| 2025-10-02 | Milnes Alistair CHIEF OPERATING OFFICER | Sale | −1,147 | $8.40 | $10K | 94,355 |
| 2025-10-02 | Lee Kevin CHIEF EXECUTIVE OFFICER | Sale | −2,263 | $8.40 | $19K | 478,541 |
| 2025-10-02 | Skynner Michael CHIEF TECHNOLOGY OFFICER | Sale | −824 | $8.40 | $7K | 119,255 |
| 2025-09-08 | Hoppenot Herve Director | Grant or award | +12,500 | 12,500 |
Page 5 of 26 · 520 trades